EBMT Statistical Unit ▲ Sign in to save

• ▲ Régis Peffault de Latour

  Centre National de la Recherche Scientifique · Inserm Medicine
  20.5k

  citations

  76

  h-index

  33

  Aachen papers
• ▲ Luuk A. Gras

  Leiden University · European Society for Blood and Marrow Transplantation Medicine
  5.08k

  citations

  32

  h-index

  51

  Aachen papers
• ▲ Junfeng Wang

  Sichuan University · Maastricht University Decision Sciences
  2.57k

  citations

  23

  h-index

  4

  Aachen papers
• ▲ Katya A. L. Mauff

  Erasmus MC Medicine
  2.51k

  citations

  23

  h-index

  8

  Aachen papers
• ▲ Linda Köster

  Leiden University · National Taiwan University Medicine
  1.84k

  citations

  23

  h-index

  109

  Aachen papers
• ▲ Dirk‐Jan Eikema

  European Society for Blood and Marrow Transplantation Medicine
  1.02k

  citations

  19

  h-index

  57

  Aachen papers
• ▲ Katerina Bakunina

  European Society for Blood and Marrow Transplantation · Erasmus MC Cancer Institute Medicine
  866

  citations

  12

  h-index

  4

  Aachen papers
• ▲ Diderik-Jan Eikema

  Leiden University Medical Center · European Society for Blood and Marrow Transplantation Medicine
  703

  citations

  14

  h-index

  18

  Aachen papers
• ▲ Paul V. Bosman

  European Society for Blood and Marrow Transplantation Medicine
  468

  citations

  10

  h-index

  13

  Aachen papers
• ▲ Jarl Mooyaart

  European Society for Blood and Marrow Transplantation Medicine
  291

  citations

  11

  h-index

  32

  Aachen papers
• ▲ Giulia Sbianchi

  University of Rome Tor Vergata · European Society for Blood and Marrow Transplantation Medicine
  265

  citations

  6

  h-index

  2

  Aachen papers
• ▲ Ivonne Martin

  Universitas Gadjah Mada Medicine
  46

  citations

  4

  h-index

  1

  Aachen papers
• ▲ Junran Ge

  European Society for Blood and Marrow Transplantation Medicine
  5

  citations

  1

  h-index

  1

  Aachen papers
• ▲ Diderik-jan Eikeman

  European Society for Blood and Marrow Transplantation Medicine
  0

  citations

  0

  h-index

  1

  Aachen papers

14 results

• Outcome of allogeneic haematopoietic cell transplantation in eosinophilic disorders: A retrospective study by the chronic malignancies working party of the EBMT

  2022 British Journal of Haematology article Medicine Eosinophilic Disorders and Syndromes Open access

  4

  citations
• Daratumumab after allogeneic hematopoietic cell transplantation for multiple myeloma is safe and synergies with pre-existing chronic graft versus host disease. A retrospective study from the CMWP EBMT

  2022 Bone Marrow Transplantation article Medicine Multiple Myeloma Research and Treatments Open access

  4

  citations
• Second allogeneic transplants for multiple myeloma: a report from the EBMT Chronic Malignancies Working Party

  2021 Bone Marrow Transplantation article Medicine Hematopoietic Stem Cell Transplantation Open access

  4

  citations
• Allogeneic haematopoietic cell transplantation for therapy-related myeloid neoplasms arising following treatment for lymphoma: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT

  2024 Bone Marrow Transplantation article Medicine Hematopoietic Stem Cell Transplantation Open access

  4

  citations
• Allogeneic Hematopoietic Cell Transplantation in Patients with Therapy-Related Myeloid Neoplasm after Breast Cancer: A Study of the Chronic Malignancies Working Party of the EBMT

  2020 Blood article Medicine Hematopoietic Stem Cell Transplantation

  4

  citations
• SARS-CoV-2 vaccination in 361 non-transplanted patients with aplastic anemia and/or paroxysmal nocturnal hemoglobinuria

  2023 Haematologica article Medicine SARS-CoV-2 and COVID-19 Research Open access

  3

  citations
• Current use of fecal microbiota transfer in patients with hematologic diseases: a survey on behalf of the Cellular Therapy and Immunobiology Working Party of the EBMT

  2023 Bone Marrow Transplantation article Medicine Hematopoietic Stem Cell Transplantation Open access

  3

  citations
• Allogeneic hematopoietic cell transplantation for therapy-related myeloid neoplasms arising following treatment for multiple myeloma: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT

  2024 Bone Marrow Transplantation article Medicine Hematopoietic Stem Cell Transplantation Open access

  3

  citations
• Carfilzomib, lenalidomide and dexamethasone followed by a second ASCT is an effective strategy in first relapse multiple myeloma: a study on behalf of the Chronic malignancies working party of the EBMT

  2023 Bone Marrow Transplantation article Medicine Multiple Myeloma Research and Treatments Open access

  2

  citations
• Early liver complications after allogeneic haematopoietic stem cell transplantation in patients with myelofibrosis: A study on behalf of the Chronic Malignancies Working Party of the EBMT

  2023 British Journal of Haematology article Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access

  1

  citations
• Survey of European Blood and Marrow Transplant (EBMT) nurses to explore the current topical skin management of chronic cutaneous graft versus host disease in the real-world clinical environment

  2024 European Journal of Oncology Nursing article Medicine Hematopoietic Stem Cell Transplantation

  1

  citations
• Upfront Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients with Idiopathic Aplastic Anemia: A Study on Behalf of the Saawp of EBMT

  2020 Blood article Medicine Hematopoietic Stem Cell Transplantation

  1

  citations
• Allogeneic hematopoietic cell transplantation for myelodysplastic syndrome unclassifiable – a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT

  2022 Bone Marrow Transplantation article Medicine Hematopoietic Stem Cell Transplantation

  1

  citations
• Autologous hematopoietic cell transplantation for T-cell prolymphocytic leukemia: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT

  2024 Haematologica article Medicine Hematopoietic Stem Cell Transplantation Open access

  1

  citations
• In the era of Bortezomib-based Induction, intensification of Melphalan-based conditioning with Bortezomib does not improve Survival Outcomes in newly diagnosed Multiple Myeloma: a study from the Chronic Malignancies Working Party of the EBMT

  2024 Bone Marrow Transplantation article Medicine Multiple Myeloma Research and Treatments Open access

  1

  citations
• Choice of commercially available CAR-T cell products for r/r DLBCL & PMBCL in Europe: a survey on behalf of the cellular therapy & immunobiology working party (CTIWP) of the EBMT

  2024 Bone Marrow Transplantation article Medicine CAR-T cell therapy research Open access

  1

  citations
• Post-Transplant Cyclophosphamide for Graft Vs Host Disease Prophylaxis in Multiple Myeloma Patients Who Underwent Allogeneic Hematopoietic Cell Transplantation: First Comparison By Donor Type; A Study from the Chronic Malignancies Working Party of the EBMT

  2020 Blood article Medicine Hematopoietic Stem Cell Transplantation Open access

  1

  citations
• Correction: Donor lymphocyte infusions after haploidentical stem cell transplantation with PTCY: A study on behalf of the EBMT cellular therapy & immunobiology working party

  2022 Bone Marrow Transplantation erratum Medicine Hematopoietic Stem Cell Transplantation Open access

  1

  citations
• Daratumumab after Allogeneic Hematopoietic Stem Cell Transplantation in Multiple Myeloma: Safety and Efficacy. a Retrospective Study from the Cmwp EBMT

  2020 Blood article Medicine Multiple Myeloma Research and Treatments

  0

  citations
• Impact of Specific Adverse Cytogenetic Features on Outcomes after Allogeneic Hematopoietic Cell Transplantation in Myelodysplastic Syndrome with Very Poor Risk Cytogenetics: A Study from the Chronic Malignancies Working Party of EBMT

  2021 Blood conference-abstract Medicine Hematopoietic Stem Cell Transplantation

  0

  citations